iBio (IBIO) Cash & Equivalents (2010 - 2026)
iBio's Cash & Equivalents came in at $56.4 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 557.2% from $8.58 million a year earlier and up 18.4% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Cash & Equivalents (2010 - 2026) Analysis & Trends
Going back to fiscal Q1 2011, iBio's Cash & Equivalents data covers 64 quarters.
- Cash & Equivalents carries a five-year compound annual growth rate of -6.1% (FY2021 to FY2026).
- Going back by fiscal year, Cash & Equivalents was $8.58 million in FY2025 (-39.6%), $14.21 million in FY2024 (+230.4%), $4.3 million in FY2023 (-81.0%) and $22.68 million in FY2022 (-70.7%).
- The fiscal Q4 2026 figure represents the highest quarterly Cash & Equivalents since fiscal Q1 2022.
- Year-over-year, Cash & Equivalents has increased for four consecutive quarters, with growth averaging 329.4% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in fiscal Q3 2026 (growth of 852.6%), and the weakest in fiscal Q2 2023 (a decline of 90.6%).
- Business Quant data shows IBIO's Cash & Equivalents at $47.63 million (Q3 2026), $28.7 million (Q2 2026) and $28.11 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | iBio | 116.55 Mn | 116.55 Mn | - | 56.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.40 Mn |
| Mar 31, 2026 | 47.63 Mn |
| Dec 31, 2025 | 28.70 Mn |
| Sep 30, 2025 | 28.11 Mn |
| Jun 30, 2025 | 8.58 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | 7.02 Mn |
| Sep 30, 2024 | 11.04 Mn |
| Jun 30, 2024 | 14.21 Mn |
| Mar 31, 2024 | 5.30 Mn |
| Dec 31, 2023 | 2.79 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 4.30 Mn |
| Mar 31, 2023 | 6.56 Mn |
| Dec 31, 2022 | 3.70 Mn |
| Sep 30, 2022 | 9.89 Mn |
| Jun 30, 2022 | 22.68 Mn |
| Mar 31, 2022 | 33.77 Mn |
| Dec 31, 2021 | 39.21 Mn |
| Sep 30, 2021 | 62.82 Mn |
API Access
iBio Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();